These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12432193)

  • 1. A 34-year-old renal transplant recipient with high-grade fever and progressive shortness of breath.
    Soman R; Vaideeswar P; Shah H; Almeida AF
    J Postgrad Med; 2002; 48(3):191-6. PubMed ID: 12432193
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongyloides stercoralis in Papanicolaou-stained smears of ascitic fluid.
    Avagnina MA; Elsner B; Iotti RM; Re R
    Acta Cytol; 1980; 24(1):36-9. PubMed ID: 6986735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent septicemia in a renal transplant recipient.
    Nejad-Gashti H; Sanavi S; Afshar R
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):471-3. PubMed ID: 19414955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal intestinal tubercolosis in a uremic patient with a renal transplant.
    Feriozzi S; Meschini L; Costantini S; Gomes V; Ranalli T; Perez M; Ancarani E
    J Nephrol; 2002; 15(5):593-6. PubMed ID: 12455729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strongyloides hyperinfection syndrome following simultaneous heart and kidney transplantation.
    Mizuno S; Iida T; Zendejas I; Martin TD; Schain DC; Turner B; Fujita S
    Transpl Int; 2009 Feb; 22(2):251-3. PubMed ID: 18954367
    [No Abstract]   [Full Text] [Related]  

  • 7. [Strongyloidiasic hyperinfestation].
    Rivas Gómez A; Mijares MS
    G E N; 1977; 32(2):205-14. PubMed ID: 97163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autopsy analysis in post-transplant patients--a basis for clinical audit.
    Ullah K
    J Coll Physicians Surg Pak; 2003 Jun; 13(6):343-4. PubMed ID: 12814534
    [No Abstract]   [Full Text] [Related]  

  • 10. End-stage renal disease due to polyomavirus in a cardiac transplant patient.
    Maddirala S; Pitha JV; Cowley BD; Haragsim L
    Nat Clin Pract Nephrol; 2007 Jul; 3(7):393-6. PubMed ID: 17592472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of myocardial infarction after kidney transplantation.
    Lentine KL; Brennan DC; Schnitzler MA
    J Am Soc Nephrol; 2005 Feb; 16(2):496-506. PubMed ID: 15615820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of renal transplantation on pulmonary function and respiratory muscle strength in patients with end-stage renal disease.
    Guleria S; Agarwal RK; Guleria R; Bhowmik D; Agarwal SK; Tiwari SC
    Transplant Proc; 2005 Mar; 37(2):664-5. PubMed ID: 15848494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rothia dentocariosa sepsis in a pediatric renal transplant recipient having post-transplant lymphoproliferative disorders.
    Wiesmayr S; Stelzmueller I; Berger N; Jungraithmayr TC; Fille M; Eller M; Zimmerhackl LB; Margreiter R; Bonatti H
    Pediatr Transplant; 2006 May; 10(3):377-9. PubMed ID: 16677365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience.
    Kramer A; Sausville J; Haririan A; Bartlett S; Cooper M; Phelan M
    J Urol; 2009 Feb; 181(2):724-8. PubMed ID: 19091353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol crystal embolic disease in renal allografts.
    Scolari F; Tardanico R; Pola A; Mazzucchelli C; Maffeis R; Bonardelli S; Maiorca P; Movilli E; Sandrini S
    J Nephrol; 2003; 16(1):139-43. PubMed ID: 12649545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspergillosis osteomyelitis and joint infection in a renal transplant recipient.
    Ersoy A; Akdag I; Akalin H; Sarisozen B; Ener B
    Transplant Proc; 2007 Jun; 39(5):1662-3. PubMed ID: 17580212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
    Kuypers DR; Claes K; Bammens B; Evenepoel P; Vanrenterghem Y
    Nephrol Dial Transplant; 2008 Jun; 23(6):2033-42. PubMed ID: 18174264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of graft survival in pediatric and adolescent live donor kidney transplant recipients: a single center experience.
    El-Husseini AA; Foda MA; Shokeir AA; Shehab El-Din AB; Sobh MA; Ghoneim MA
    Pediatr Transplant; 2005 Dec; 9(6):763-9. PubMed ID: 16269048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of living-related renal transplant from the donor with membranous nephropathy.
    Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
    Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.